Mesh Bio is a Singapore-based health deep tech startup that focuses on developing digital twin technologies for chronic disease management. The company aims to address the growing global clinical burden of metabolic diseases due to the aging population and challenges in care delivery. Mesh Bio develops clinical decision support analytics and automation solutions for the management of chronic diseases, such as cardiovascular disease. Their solutions enable data-driven care delivery, improving patient engagement and health outcomes.

Mesh Bio

TechNode Global is a spin-off of TechNode, China’s leading innovation and entrepreneurship platform. We aim to be the #1 Pan-Asia tech platform with a focus on premium tech news, cross-border businesses, events, and tailor-made marketing solutions for startups, VCs, corporates and other industry pioneers. With a vast network in global innovation and entrepreneurship, TechNode Global facilitates interactions and cross-pollination between China and APAC’s sharing economy.

Subscribe to our monthly newsletter to stay updated on the latest news, events, and happenings: https://bit.ly/3xDeifB

Nutty Capital Venture

SPH Ventures

Kairous Capital

TechNode Global

South Korea's SK Telekom partners Singapore's Singtel to grow #metaverse business in Asia Pacific

Singapore's Igloo raises additional $27M, bringing Series B total funding round to $46M

The "Thailand Accelerator" project was launched in collaboration with 25 partners to assist startups in raising funds as well as accelerating and enhancing their growth in the regional arena.

Flexible and remote work is here to stay, says Solos CEO Ricky Willianto

Singapore's ComfortDelGro partners Indonesia's Gojek to tackle transport industry issues

Indonesia's TipTip raises over $13M Series A Funding led by East Ventures

India's Celebal Technologies gets $32M investment from Norwest Venture Partners

Wise, one of British largest and best-known #FinTech unicorns, came into the limelight last year when the money transfer firm opted to list in London through a direct listing, a rare method of going public pioneered by music streaming firm Spotify in the US in 2018. Rather than raising money in an IPO, Wise’s private backers are selling their existing shares to the public, CNBC reported.

The GrowHub partners ManukaLife to distribute honey products in Southeast Asia, China, helped by #Web3 tech

Singapore's SC Capital Partners teams up ADIA to form Asia Pacific data center investment program

GLOBAL:TECHNODE

Mesh Bio

Financials Not Available